University College London - United Kingdom
Author Profile
Early Academic Pursuits
Dr. Kersti Karu embarked on her academic journey with a strong foundation in Chemical Engineering, earning her Bachelor of Science degree from Tallinn Technical University. Building upon this, she pursued her passion for analytical chemistry by obtaining a Master of Science degree in Analytical Chemistry from UCL Birkbeck College. These formative years laid the groundwork for her illustrious career in research and academia.
Professional Endeavors
Dr. Karu's professional journey commenced in 2001 at UCL School of Pharmacy, where she began her research as a mass spectrometrist. Over the years, she honed her expertise in mass spectrometry analysis, delving into various applications spanning small molecules, proteins, peptides, DNA, and RNA. Her dedication and commitment led her to complete her Ph.D. in Liquid Chromatography Mass Spectrometry (LC-MS) methods tailored for sterol analysis, under the guidance of Professor William J Griffiths.
Transitioning to Imperial College London, Dr. Karu expanded her research horizons, focusing on identifying pain-related proteins in the brain using proteomics techniques. This period marked her foray into interdisciplinary research, blending mass spectrometry with neuroscience to unravel complex biological phenomena.
Joining UCL Chemistry Department in 2013 as the Mass Spectrometry Manager showcased Dr. Karu's leadership capabilities as she spearheaded various projects, ranging from small molecule identification to antibody-conjugate analysis. Additionally, her role in supervising MSc projects underscores her commitment to nurturing the next generation of analytical chemists.
Contributions and Research Focus
Dr. Karu's research revolves around the biosynthesis and metabolism of phytosterols and cholesterol, exploring their implications for human health. Noteworthy is her collaboration with UCL Queen Square Institute of Neurology, where she established analytical methods for analyzing bile acids and sterols in biological samples, contributing to the understanding of neurological disorders. Furthermore, her partnership with UCL Bloomsbury Institute of Intensive Care Medicine shed light on the involvement of cholesterol and its metabolites in sepsis, highlighting the broader impact of her research on critical care medicine.
Accolades and Recognition
Dr. Karu's contributions to the field of analytical chemistry have garnered significant recognition, reflected in her authorship of 40 peer-reviewed papers with over 1053 citations. Her impressive h-index of 16 underscores the influence of her research within the scientific community.
Impact and Influence
Dr. Karu's multidisciplinary approach to research, bridging chemistry with neuroscience and medicine, has paved the way for groundbreaking discoveries. Her innovative methods for mass spectrometry analysis have not only advanced scientific knowledge but also found practical applications in diverse fields, from pharmaceuticals to environmental monitoring.
Legacy and Future Contributions
Dr. Karu's legacy lies in her unwavering dedication to advancing analytical chemistry and its applications in understanding complex biological systems. As she continues her academic journey, her future contributions are poised to shape the landscape of mass spectrometry and its role in addressing pressing healthcare challenges.
In conclusion, Dr. Kersti Karu's remarkable academic pursuits, professional endeavors, and impactful research underscore her as a trailblazer in the field of analytical chemistry. Her interdisciplinary approach, coupled with her commitment to mentorship and collaboration, positions her as a beacon of innovation and excellence in academia.